Mounjaro to be covered by Gesy for diabetes and adult obesity
The anti-obesity drug Mounjaro will be covered by Gesy for Type II diabetes and obesity in adults from Thursday, the health insurance organisation has announced. Coverage of tirzepatide, the drug’s active ingredient, will be subject to approved protocols. The revised protocol for Ozempic (semaglutide) for Type II…
Full story on the publisher’s site.